<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-9QZW4IK5</identifier><date>2015</date><creator>Flisar, Dušan</creator><relation>documents/doc/9/URN_NBN_SI_doc-9QZW4IK5_001.pdf</relation><relation>documents/doc/9/URN_NBN_SI_doc-9QZW4IK5_001.txt</relation><format format_type="issue">1</format><format format_type="volume">66</format><format format_type="type">article</format><format format_type="extent">str. 19-22</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">281542144</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-9QZW4IK5</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">drug</subject><subject language_type_id="slv">Parkinsonova bolezen</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravila</subject><subject language_type_id="slv">zdravljenje</subject><title>Treatment of Parkinson's disease</title><title>Zdravljenje Parkinsonove bolezni</title></Record>